Stoke Therapeutics, Inc. — Director's Dealing 2020

Mar 26, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Stoke Therapeutics, Inc. (STOK)
CIK: 0001623526
Period of Report: 2020-03-25

Reporting Person: Tulipano Stephen J (CFO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-03-25	Employee Stock Option (Right to Buy)	$20.25	A	60000	Acquired	2030-03-24	Common Stock (60000)	Direct

Footnotes

F1: The option vests as to 1/48th of the total shares on April 25, 2020 and then 1/48th of the total shares vest monthly thereafter, subject to reporting person's continued service to the issuer through each vesting date.